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Central Neurochemical Mechanisms Involved in the Generation of the Preovulatory
GnRH Surge in Normally Cycling Proestrous Female Rats
Committee Chairman: Craig A. Johnston
A number o f central neurotransmitters have been implicated in the cyclic control of
gonadotropin-releasing hormone (GnRH) secretion from the median eminence (ME) of
the basal hypothalamus (BH) in normally cycling female rats. The large surge of this
hormone released on the afternoon of proestrus stimulates secretion o f luteinizing
hormone (LH) from the pituitary, thereby driving ovulation. Among the central
neurotransmitters thought to play a stimulatory role in the preovulatory, proestrous
release o f GnRH are norepinephrine (NE), oxytocin (OT), and nitric oxide (NO). The
purpose of this research was to investigate the role o f these neurotransmitters in
stimulating GnRH release from BH explants in vitro, in order to better understand how
they may be working in vivo.
It was found that OT stimulated GnRH release from BH explants, but not ME
fragments harvested on the afternoon of proestrus from normally cycling female rats.
This suggests that the connectivity o f the intact BH is required for OT to stimulate
proestrous GnRH release. The ability o f OT to stimulate proestrous GnRH release from
BH explants was blocked by OT receptor antagonism, and by NO synthase (NOS)
inhibition. NE was also found to stimulate GnRH release from proestrous BH explants.
Alpha-1, but not alpha-2 adrenergic receptor antagonism blocked the ability of NE to
stimulate proestrous GnRH release from BH explants. OT receptor antagonism
attenuated, but did not entirely block the effect of NE on GnRH release. When used in
combination, NE/OT synergistically stimulated GnRH release from proestrous BH
explants. This is the first report of this effect. NE/OT- induced stimulation o f proestrous
GnRH release from BH explants was blocked by OT receptor antagonism, and by
inhibition of NOS. The results suggest that combined NE/OT stimulate GnRH release
from proestrous BH explants in a synergistic manner, using OT- receptor and NO
mediated mechanisms.
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Chapter 1: Introduction
Scientists have studied the control o f reproductive cycles since the discovery and
characterization of the gonadal endocrine steroids, estradiol and progesterone, in the
1930’s. In the late 1940’s and early 1950’s, connections between the brain and the
pituitary were elucidated, and the field o f neuroendocrinology founded (Harris 1955;
Bargmann and Scarrer 1951). In 1955, the possibility that the brain controls anterior
pituitary gland function via the hypothalamic hypophysial portal blood system was first
suggested (Harris 1955). Central nervous system (CNS) regulation o f fertility-related
pituitary function was first shown when Kalra (1971) demonstrated that electrochemical
stimulation of the medial preoptic area (MPO) of the hypothalamus evoked the release of
luteinizing hormone (LH), which drives ovulation, from the pituitary gland. In the early
1970’s it was demonstrated that CNS-controlled pituitary function depended on
circulating levels o f estradiol and progesterone produced by the ovaries (Tepperman
1980), and the primary hypothalamic LH-releasing factor, gonadotropin-releasing
hormone (GnRH), was characterized (Schally et al. 1972; Yen and JafFe 1986). Since that
time, the effect of many endogenous CNS neurotransmitter systems on GnRH release and
fertility cycles have been described, but a clear picture of how the brain controls these
cycles has not been determined. Also unresolved is how the peripheral endocrine system
signals the brain that the peripheral reproductive organs are prepared for ovulation, and
the timing for the preovulatory surge o f LH is perfect. Figure 1-1 summarizes the
feedback loops involved in the generation o f the preovulatory GnRH surge and ovulation.
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Regulation of Fertility: Gonadal Steroids and the Estrous Cycle
Because o f its overall physiological similarity to the human and short estrous
cycle, the rat is frequently used as a model for studying female fertility. Rats have a four
to five day estrous cycle, which is characterized by cyclically changing hormone levels
(Figure 1-2), and corresponding changes in vaginal cytology. The first day o f the cycle is
called metestrus (or diestrus one). Reproduction-specific gonadal and hypothalamic
hormone levels remain low during metestrus. The second day of the cycle is diestrus (or
diestrus two). Hormone levels remain quiescent until very late in diestrus, when estradiol
levels slowly begin to rise. During proestrus, the third day o f the cycle, estradiol levels
continue to rise, reaching a peak in the late afternoon. On the afternoon of proestrus,
progesterone levels also rapidly rise. The timing of the increases in these two gonadal
hormones (especially estradiol), in turn, somehow signals the hypothalamus to secrete a
large pulse of the hypothalamic hormone, GnRH, from the median eminence (ME). This
hypothalamic hormone stimulates the preovulatory surge of LH release from the anterior
pituitary. The final day o f the cycle is estrus, the fertile period. During estrus, levels of
LH and GnRH are low, whereas estradiol and progesterone levels remain physiologically
high. It is the unknown signal(s) that mediate this important feedback of peripheral
gonadal hormones to the brain, signaling that the time is right for ovulation, and
stimulating GnRH release on proestrus, which is the particular focus of the studies
outlined in this dissertation.
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Luteinizing Hormone and Ovulation
LH is a 30,000 MW glycoprotein that is synthesized and secreted from
gonadotropes in the anterior pituitary. In female rats and other mammals, LH and follicle
stimulating hormone (FSH), another glycoprotein made in the anterior pituitary, are
necessary for final follicular growth and maturation leading to ovulation. Both hormones
consist of two polypeptide chains linked by hydrogen bonds and internal cross-linking
disulfide bonds. LH and FSH are composed o f identical 89- amino acid alpha chains, and
a 115- amino acid beta chain unique to each hormone. Complex carbohydrate side chains
are attached to specific locations on both the alpha and beta chains. The alpha and beta
chains are synthesized separately and are combined before addition o f the carbohydrate
moeities.
FSH and LH bind to high affinity receptors in the ovaries that are glycoprotein
encoded by homologous genes and are characterized by seven transmembrane-spanning
domains. A large extracellular N-terminus region forms the specific binding site for each
gonadotropin. The C-terminus is intracellular and mediates receptor down-regulation, and
the generation of second-messenger signals. Both LH and FSH receptors demonstrate
distinctive calcium signaling properties, and when bound by agonists activate adenylyl
cyclase. The cAMP generated then triggers the activation of its protein kinase and
subsequent phosphorylation of proteins necessary for steroidogenesis and ovulation.
During the follicular phase of the estrous cycle, FSH stimulates several follicles to
accelerate maturation by binding to its receptors on the granulosa cells, leading to an

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

4

increased enzymatic activity to aromatize androgens to estradiol. As estradiol levels
increase and follicles develop, FSH levels drop and the developing follicles begin to
synthesize increased numbers of LH receptors. On proestrus, positive feedback from
estradiol causes a large surge o f GnRH release, which then stimulates LH release. This
LH induces the production o f prostaglandin F2-aIpha, progesterone and proteolytic
enzymes at the follicular level. These ultimately cause follicular rupture and ovulation.
Recent data indicate that increases in progesterone itself, or a similar adrenal steroid, may
actually preceed the LH surge and contribute to its stimulation and timing. At any rate,
following ovulation, the corpus luteum continues to make and secrete progesterone to
prepare the uterus for implantation of a fertilized ovum. The high concentrations o f
estradiol and progesterone present just after ovulation then cause negative feedback upon
GnRH, FSH and LH release. The resulting drop in LH secretion prevents further
production o f estradiol and progesterone. As the concentration o f these gonadal steroids
decrease, the degenerating uterine endometrial cells are attacked by leukocytes, preparing
the reproductive system for its next cycle.

GnRH

GnRH, also known as luteinizing hormone-releasing hormone (LHRH), is a
decapeptide hormone and neurotransmitter. GnRH neuron cell bodies originate in the
MPO and the organum vasculosum of the lamina terminalis (OVLT) o f the rostral
hypothalamus (RH). They are widely distributed and few in number (Carillo 1980).
GnRH projections are sent from the MPO to the ME, where GnRH is secreted into the

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

5

hypophysial portal blood, which carries the hormone to a second capillary bed in the
sinusoids o f the anterior pituitary, where GnRH binds to specific seven-transmembrane,
G-protein coupled receptors.
In addition to being located in the anterior pituitary, GnRH receptors are also
found in various other areas of the brain. These include the ventromedial nucleus o f the
hypothalamus (VMN), the lateral septal nucleus, the anterior cingulate cortex, and the
subiculum (Jennes and Conn 1994). GnRH stimulation o f these receptors is thought to
mediate sex-related behaviors such as lordosis in the female rat. Thus, GnRH has central
effects in addition to its role in stimulating LH and FSH release from the pituitary gland.
Activation o f the GnRH receptor is coupled to the Gq/Gl 1 signal transduction
system, which activates phospholipase C. This enzyme leads to the generation o f several
second messenger molecules. Among these, diacylglycerol (DAG) and inositol 1,4,5-trisphosphate

(EP3)

are critically important. Inreased in DAG leads to activation o f protein

kinase C, which causes a series o f intracellular changes, and EP3 causes increased release
o f calcium from intracellular pools (Diedricht 1999). GnRH receptor synthesis is subject
to a positive feedback loop, whereby the levels of receptor-bound GnRH positively
influence GnRH receptor synthesis (Stojijlkovic et al. 1994). Thus, one result o f the
signal transduction pathway for GnRH receptor stimulation is that transcription and/or
translation o f GnRH receptor genes is increased upon binding.
GnRH synthesis and release in the female rat is linked both to increased
intracellular calcium levels in GnRH neurons, and transcription of a number of important
immediate early genes (IEG), especially Fos and Jun (Finn, Steiner, and Clifton 1998).
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This is important to note, as a number o f studies using EEGs as markers o f cellular
activity have identified areas in the medialbasal hypothalamus (MBH), other than the
ME, which are important for the cyclic synthesis and release o f GnRH in the female rat.
Further, increased Fos induction is seen in GnRH neurons on the afternoon of proestrus
in female rats (Hoffman, Smith and Verbalis 1993; Hoffman 1993), and GnRH genes are
plausible targets for activation by Fos and Jun (Berriman 1992).

Control of GnRH Release
Pulsatile GnRH release is regulated, in part, by circulating gonadal steroid levels.
At most times during the reproductive cycle estradiol and/or progesterone provide
negative feedback to GnRH and LH release. However, GnRH release can be stimulated
by progesterone administered to estradiol primed, ovariectomized (OVX) animals
(Levine 1997). This effect can be blocked when progesterone receptors are antagonized
(Chappel and Levine 2000), which indicates an important role for both gonadal steroid
hormones in the generation of the proestrous GnRH surge. Interestingly, GnRH neurons
do not express appreciable estradiol or progesterone receptor protein (Simonian and
Herbison 1997), and thus are thought to indirectly sense changing levels of gonadal
steroids. However, estradiol and progesterone receptors are present on a number o f other
neuronal phenotypes, many o f which make connections with GnRH neurons. It is
hypothesized that it is through these neurons that the brain detects peripheral estradiol
and/or progesterone levels in order to regulate GnRH secretion.
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A number o f central neurotransmitters have been shown to influence GnRH
synthesis and release, and thus LH synthesis and release. These are summarized in Table
1-1. Norepinephrine (NE), neuropeptide Y (NPY), glutamate, oxytocin (OT), and galanin
all have been shown to stimulate GnRH release. NE seems to play a role in both the
preovulatory, proestrous GnRH surge, and in regulating basal secretion throughout the
estrous cycle (Legan and Callahan 1999). Both NPY and glutamate are involved in
stimulating the proestrous surge at the level o f the ME, where GnRH is released (Prevot
et al. 1999). OT’s role is negligible on all days of the cycle other than proestrus.
However, on the afternoon o f proestrus, OT has been shown to stimulate the preovulatory
LH surge when given directly into the CNS (Johnston et al. 1992). Interference with
endogenous OT via antibodies, OT receptor antagonism, conjugation o f OT with the
neurotoxin ricin, or OT antisense administration on the afternoon of proestrus blocks or
attenuates the preovulatory GnRH and/or LH surge (Johnston et al. 1992; Johnston et al.
1990; Cheesman et al. 1977; Samson et al. 1992). Galanin has also been implicated in the
stimulation of GnRH release on proestrus. Galanin mRNA has been localized on GnRH
neurons and is dramatically upregulated during proestrus and estrus (Finn et al. 1998).
Further, upregulation of galanin gene expression has been linked to the GnRH and LH
surges (Finn et al. 1998). The galanin gene may be a target for activation by Fos and Jun,
the two IEGs associated with estradiol- induced GnRH release (Hrabosvky 1995). Thus,
several neurotransmitters have been implicated in the stimulation o f GnRH release.
Agents inhibitory to GnRH secretion include beta-endorphin, y-aminobutyric acid
(GABA), and corticotropin releasing factor (CRF). Beta-endorphin is involved in the
tonic regulation o f GnRH secretion, and administration of a beta-endorphin agonist
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attenuates the GnRH surge (Polkowska, J and Przekop, 1997). CRF, which is secreted in
response to stress, is also a potent inhibitor of proestrus GnRH secretion (Polkowska and
Przekop 1997). The fact that stress is one of the most common causes of female infertility
relates directly to this phenomenon.
That so many neurotransmitter systems influence GnRH release makes sense from
an evolutionary standpoint, as reproduction can continue despite the loss of one the
controlling factors o f GnRH release. For instance, both chronic blockade of alphaadrenergic receptors, and lesions o f noradrenergic neurons in the locus ceureleus abolish
normal reproductive cycles in the rat. However, normal reproductive cycles return after a
few weeks, and further manipulations of the noradrenergic system have little effect on re
established pulsatile GnRH release. Thus, it appears that the loss o f one neuronal system
involved in control o f cyclic GnRH release can be compensated for by the actions of
others. This represents an important principle o f redundancy, which enhances the
likelihood o f survival o f the species (Berriman, 1992).

Norepinephrine

NE has been implicated in the regulation of both tonic and pulsitile GnRH release
(Legan and Callahan 1999; Gallo 1980). This catecholamine is made primarily in the
locus ceuruleus of the caudal midbrain and upper pons o f the brainstem. From there, Al
and A2 NE projections are sent to targets throughout the brain, including several involved
in reproductive behavior. These include the preoptic area (POA), MPO (Legan and
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Callahan 1999) and the PVN (Daftary, Boudaba, and Tasker 2000). NE neurons in the
A l field have estradiol receptors (Simonian and Herbison 1997b), and NE turnover in the
MPO as well as the ME parallels changes in circulating LH concentrations, such that NE
secretion increases around the time o f the preovulatory LH surge (Crowley et al. 1978;
Honma and Wutke 1980). Moreover, immunocytochemistry (ICC) and in situ
hybridization studies reveal there are synaptic contacts between noradrenergic terminals
and GnRH cells in the POA (Barraclough and Wise 1982; Kalra and Kalra 1983).
NE binds to several different receptor subtypes. In terms o f NE’s effects on
fertility and sexual behavior, alpha- adrenergic receptors have been most implicated.
Antagonism of NE alpha- adrenergic receptors by administration of phenoxybenzamine
blocks the LH surge (Weick 1978), as does blockade o f NE synthesis (Legan and
Callahan 1999) in female rats. In OVX female rats, intracereberbroventricular (ICV)
administration o f 5-amino-2,4-dihydroxy-methylphenylethylamine, a selective depletor
of brain norepinephrine, reduces GnRH mRNA levels (Kang et al. 1998). In vitro
administration o f the catecholaminergic depletor, 6-hydroxydroxydopamine, to MBH
explants reduced GnRH mRNA levels, and this reduction was reversed by treatment with
NE (Kim et al. 1993), indicating a direct effect of NE on GnRH synthesis.

N-(2-

chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4), a highly selective NE neurotoxin,
suppressed estradiol stimulated GnRH release in vitro, reduced levels of GnRH mRNA in
the POA, and caused a reduction of GnRH-receptor mRNA in the pituitary (Kang et al.
1998). In the OVX ewe, another animal frequently used in fertility studies, levels of
statically expressed dopamine p-hydroxylase, the enzyme which converts dopamine to
NE within synaptic vesicles, decreased in the MPO in estradiol-primed, OVX animals as
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visualized by ICC (Kotwica et al. 1996). This was thought to indicate an increase in
conversion of dopamine to NE during the late follicular stage o f the ewe, which parallels
proestrus in rats. In the rabbit, LH surges are induced following coitus, and this induction
has been linked to increased release of NE in the MBH (Kaynard et al. 1990). Thus, data
from a variety of species indicate an important role for NE in the GnRH and LH surges.

Oxytocin
Another putative stimulator of GnRH is OT. OT is a nanopeptide hormone and
neurotransmitter, and is very similar to arginine vasopressin (AVP) in structure but not
function. OT cell bodies are concentrated in the anterior portion of the paraventricular
(PVN) and in the supraoptic (SON) nuclei of the hypothalmus (Peterson and Guillemin
1974). The main projection o f OT neurons is to the posterior pituitary, where it is
secreted as a hormone in response to suckling in nursing mammals, at the onset of
parturition, and in response to stress. Projections are also sent to the ME, where it has
been postulated that OT stimulates GnRH secretion (Rettori et al. 1974), and where OT is
released into the hypophysial portal blood to influence anterior pituitary activity. Other
OT projections are sent to areas in the hypothalamus containing GnRH cell bodies
including the MPO, the OVLT, and the VMN. Sub-populations of OT neurons display
nuclear estradiol receptors, and these may be involved in OT’s role in stimulating GnRH
(Dufau and Catt, 1978).
The OT receptor is very similar to that for vasopressin. It belongs to the Gprotein coupled, seven transmembrane receptor family. In the periphery, OT receptors are
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found in the uterus, mammary gland, and pituitary lactotropes and corticotropes. In the
brain, the receptor is found in a variety o f nuclei involved in both the GnRH surge and
sexual behavior. These include the VMN, the MPO, the OVLT, and the SON (Ludwig
1995). Activation o f the OT receptor is coupled to the inositol phosphate (EP3)/ calcium
second messenger system. OT binding thus causes an increase in IP3, DAG, and
ultimately, free intracellular calcium. It has been postulated that there are subtypes o f OT
receptors specific for 4-90T, a potent metabolized version of OT in the brain, but these
have not been characterized (Lopes-da Silva, Adan and Burbach 1993).
OT and OT receptor mRNA both are influenced by circulating estradiol levels
(Bale et al. 1995; Quinones-Jehab et al. 1997). In OVX animals, estradiol- priming
increases OT mRNA levels in the rat hypothalamus, and this phenomenon is greatly
enhanced when progesterone is initially administered with estradiol, then subsequently is
slowly withdrawn (Bale at al. 1990). Message expression o f the OT receptor varies
throught the estrous cycle, with a 15-fold increase in that expression being seen in the
VMN from the morning to the afternoon o f proestrus (Bale, Dorsa, Johnston 1995). This
supports a role for changing estradiol and progesterone levels in the regulation o f OT
synthesis.

Further, the rat OT gene contains a consensus sequence for an estradiol

response element (Quinones-Jelab et al. 1997).
While central administration o f OT has previously been shown to stimulate
elevated plasma LH on proestrus (when estradiol levels are high), but not on metestrus or
diestrus (Johnston et al. 1992), whether OT directly stimulates GnRH on proestrus in the
female rat is not known. Presumably it does, since the effect o f OT on LH stimulation is a
centrally mediated phenomenon and can be blocked by central administration of both OT
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antisera and a GnRH antagonist (Johnston et al. 1990). However, this has yet to be
proven. Another unknown is the site in the brain where OT is working to stimulate LH
release. These represent two o f the primary questions examined in the research for this
dissertation.

Nitric Oxide
Nitric oxide (NO) has been shown to play a role in cyclic GnRH release in the
female rat both at the level o f the ME and in the MBH (Herbison et al. 1996). NO is
synthesized by a number of related NO-synthase (NOS) molecules in neurons,
endothelial cells, platelets, and neutrophils in response to homeostatic stimuli (Mondcada
1992). NOS is a complex enzyme which acts on molecular oxygen and arginine to
produce NO and citrulline. This process involves five essential cofactors and two divalent
cations (calcium and heme iron). NO interacts with the heme prosthetic group of
guanylate cyclase, activating the enzyme and leading to increased cylcic GMP levels.
Evidence has been presented for a role o f constituitively expressed neuronal NOS
(nNOS) and endothelial NOS (cNOS), in the stimulation of LH and GnRH release on the
afternoon o f proestrus in female mammals (Lamar et al. 1999; Lozach et al. 1998).
Several lines of evidence also provide evidence that NO plays a role in the
stimulation o f GnRH during proestrus. NO feeding via the nitrogen donor, sodium
nitroprusside, enhances proestrous GnRH secretion in vitro (Bonavera et al. 1993; Mani
et al. 1994). NO synthesis in the MBH, as measured by the by-product o f NOS synthesis
o f NO, citrulline, is highest on the afternoon o f proestrus (Canteros et al. 1996). In the
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ME, estradiol has been shown to stimulate NO release from endothelial cells in ME
explants, and this stimulation of NO was accompanied by increased release of GnRH
from GnRH nerve terminals. These effects were blocked by administration of the
estradiol antagonist, tamoxifen (Prevot et al. 1999). Further, it has been shown that when
NO-

stimulated

guanylyl

cylclase

activation

was

inhibited

using

1H-

(l,2,4)oxadiazolo(4,3a)quinoxalin-l-one (ODQ), a potent and selective inhibitor o f NO
sensitive guanylyl cyclase, estradiol stimulated GnRH release from the ME is eliminated
(Prevot et al. 1999).

nNOS mRNA has been demonstrated to be present in the

immortalized GnRH synthesizing cell line, GT1, and these cells also produce the by
product o f NO synthesis, citrulline.
No

evidence

for

nNOS

in

GnRH

cells

has

been

demonstrated

immunocytochemically in vivo. However, Herbison et al. (1996) reported a distinct band
of nNOS containing- neurons in the MPO abutting GnRH cell bodies. Neurons
containing neural NO synthase (nNOS) are also found in various locations in the
hypothalamus that have been linked to reproduction, especially the PVN and SON
(Amico et al. 2000). These neurons have axons projecting to the ME and extending into
the neural lobe, where the highest concentration o f NOS immunoreactivity is found in the
rat brain (McCann 1998). Further, NOS- like activity has been demonstrated in the MPO
and VMN, and this, in conjunction with the previously discussed biochemical
information, indicates that NO could be involved in both the generation of the GnRH
pulse, and in GnRH mediated reproductive behaviors.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

14

Interaction Between the OT. NE. and NO Systems on Reproductive Behaviors

Interaction between the OT, NE, and NO systems on GnRH release has been
demonstrated in several different ways. Anatomically, two or more o f these systems have
been shown to overlap in the VMN, MPO, SON, PVN, and ME regions via histochemical
techniques (Mcann et al. 1998; Rettori et al. 1997; Daftary, Boubadaba, and Tasker
2000). As mentioned earlier, Fos induction in the hypothalamus has been shown via ICC
to be a precursor o f GnRH synthesis and release in female rats on the afternoon of
proestrus. Both NE and OT have been linked to induction o f Fos in the SON and the PVN
(Conde et al. 1996; Flanagan et al. 1993), and it has been shown that NE stimulates OT
release as well as Fos induction in the PVN (Bealer and Crowely 1999). Further, NOScontaining neurons in the SON have been shown to synthesize OT as well as express Fos
(Hatakeyama et al. 1996). Thus, there is strong anatomical proof o f overlap between
these three neurotransmitter systems in hypothalamic areas known to be involved in the
generation of the GnRH surge.
In addition to anatomical evidence for interaction between NE, OT, and/or NO,
links between the three have been made via biochemical investigation. As previously
mentioned, the NE, OT and NO neurotransmitter systems have been shown to be
sensitive to changing estradiol levels. Other evidence indicates that these responses to
estradiol might be interlinked. Vincent and Etgen (1993) demonstrated that steroid
priming via estradiol promotes OT- induced NE release in the VMN in female rats in
vivo. OT has been shown to influence NO synthesis in the MBH, and NE influences NO
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at both the level o f the ME and the MBH in males (Rettori et al. 1997). Taken together,
this evidence indicates significant interaction and interplay between these three systems
in the generation o f GnRH release, and GnRH mediated reproductive behaviors. These
interactions are the major focus o f the research presented here.
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Figure 1-1. Schematic of events involved in ovulation. Estrogen and progesterone levels
are sensed by the hypothalamus, resulting in the secretion o f gonadotropin-releasing
hormone (GnRH) into the portal blood at the median eminence. GnRH travels from there
to the pituitary, where it stimulates its receptors. This in turn causes the release of
luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the pituitary,
which stimulate receptors in the ovaries, ultimately causing follicular rupture and
ovulation.
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Figure 1-2. (opposite page). Approximate secretion levels o f gonadortropinreleasing hormone (GnRH), luteinizing hormone (LH), estradiol, and
progesterone throughout the rat estrous cycle. The vertical dotted line
indicates the time of ovulation.
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Table 1-1 Neurotransmitters Involved in the Central Control of GnRH Release
Neurotransmitter

Action on GnRH/LH

Site(s) of Action

Origin

Norepinephrine

Stimulatory/Inhibitory

ME, MBH

Brainstem

Glutamate

Stimulatory

ME, Pituitary (?)

MBH, many other
brain areas

Oxytocin

Stimulatory on proestrus

BH(?), ME(?),

PVN, SON

Pitiuitary (?)
Nitric Oxide

Stimulatory on proestrus

ME, MBH,
Pituitary

Galanin

Stimulatory

ME, MBH

B-endorphin

Inhibitory (Tonic)

ME, MBH

VMN

GAJBA

Inhibitory

ME, MBH

VMN (terminals)

CRF

Inhibitory

ME, MPO, OVLT

Hypothalamus
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Specific Aims
The specific aims of this research are to:

1. Investigate the role of OT in the generation of the preovulatory GnRH suge by
determining whether OT is able to stimulate GnRH release from ME or BH
explants harvested on the afternoon of proestrus from normally cycling female
rats.

2. Develop a dose-response curve for OT- induced stimulation o f GnRH from
proestrous BH explants.

3. Examine the mechanisms of OT- induced stimulation of GnRH release by testing
whether OT and alpha- adrenergic receptor antagonists, or NOS inhibition, can
influence OT- induced stimulation of GnRH release from proestrous BH explants.

4. Investigate the role of NE in the generation of the preovulatory GnRH surge by
determining if NE can stimulate GnRH release from BH explants harvested on the
afternoon o f proestrus from normally cycling female rats, and develop a doseresponse curve for NE- induced stimulation of GnRH release from proestrous BH
explants.
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5. Examine the mechanisms o f NE- induced stimulation o f GnRH release by testing
whether OT and alpha- adrenergic receptor antagonists can influence NE- induced
stimulation o f GnRH release from proestrous BH explants.

6. Investigate whether there is interaction between NE and OT on stimulating GnRH
release by examining the ability of sub-maximal doses o f OT or NE alone, or in
combination, to stimulate GnRH release from proestrous BH explants.

7. Examine the mechanisms of combined NE/OT- induced stimulation of GnRH
release by testing whether OT and alpha- adrenergic receptor antagonists, or NOS
inhibition, can influence NE/OT- induced stimulation o f GnRH release from
proestrous BH explants.

8. Investigate the role of NO in NE/OT- induced stimulation o f proestrous GnRH by
determining whether NE and/or OT can stimulate NO synthesis in proestrous BH
explants, and test the ability of OT receptor antagonism on NE/OT- induced NO
stimulation.

9. Examine the ability o f NE and/or OT to stimulate GnRH and NO from BH
explants harvested on the afternoons of estrus and diestrus versus proestrus.
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Chapter 2: Materials and Methods
Animals
Young adult female Sprague-Dawley rats (Simonson Labs, Gilroy, CA) weighing
200-250 grams were housed four to a cage, with food and water ad libitum, in an
AAALAC accredited vivarium. Room temperature was kept at 23 + 1°C, with lights on
from 0700hr to 1900hr. Only animals displaying two consecutive, normal four to five day
estrous cycles were used in these experiments.
After at least one week o f acclimatization to new housing and lighting conditions,
rats were handled daily in order to accustom them to being manipulated by the
researcher. Following several days o f handling, tails were marked for individual
identification. Vaginal cytology was then examined daily using a vaginal lavage method:
A) the animal was picked up and placed feet first on the tester’s forearm, B) the tail was
raised and a glass eyedropper with a small amount of water (approximately 0.5ml) was
inserted into the vagina, C), after lavage, the eyedropper fluid was smeared onto
numbered, clear glass slides and left to air dry, D) slides were then immersed for five
seconds in 100% methanol for fixation, and after drying, in 0.05% methylene blue in
ddH20 for approximately two minutes, then, E) slides were washed three times in fresh
cold water, and set to air dry. Slides were examined using a light microscope at 10X
magnification in order to determine the changes in vaginal cytology, and stage o f the
cycle.
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Figure 2-1 demonstrates how the estrous cycle is readily discemable via light
microscopy examination o f vaginal cytology. The first day o f the cycle is called diestrus
one, or more commonly, metestrus. The influence of estradiol or progesterone is minimal
on metestrus, and vaginal cytology reveals a sea of leukocytes descending upon,
surrounding and destroying the comified cells of estrus to begin another cycle. The
second day of the cycle is called diestrus two, or simply diestrus. On diestrus, when
estradiol exerts a limited influence, vaginal cytology consists o f a small number o f any or
all cell types, including leukocytes, epithelial and comified cells. On the third day of the
estrous cycle, proestrus, high levels o f estradiol and increasing levels o f progesterone
stimulate induction of the preovulatory GnRH surge. Vaginal cytology on proestrus
reveals an abundance o f small, round, nucleated epithelial cells, which often clump
together or align in strands. On the fertile day of the cycle, estrus, vaginal cytology, under
the strong influence of progesterone and estradiol, reveals large, enucleated comified
cells, which tend to clump together. These cells are rich in nutrients, and should an egg
be fertilized, provide an excellent environment for implantation and nutrition.

Tissue Preparation

At 1500hr, animals determined to be at the proper stage of the estrous cycle were
decapitated. Brains were quickly removed and the basal hypothalamus (BH) or ME was
rapidly dissected using a dissecting microscope and fine iris scissors. The tissues were
immediately placed in 0.5 ml preincubation Krebs-Ringer Bicarbonate buffer medium
(pH 7.4) supplemented with 1.8 mg glucose, 10 ug/ml ascorbic acid, 1.3 mM Ca2+, and 1
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mg/ml aprotinin (KRBG) for 30 minutes. All incubations were carried out in a metabolic
shaker (30 cycles/min, supplied with 95% 02/5% CO2 at 37°C). The 30 minute
preincubation period was determined empirically as the minimum time necessary for
stable, basal GnRH secretion to be restored following harvesting o f tissue. The
preincubation media was discarded and replaced following 30 minute increments with 0.5
ml KRBG, alone, to determine basal (control) GnRH secretion levels, or KRBG
containing OT (10’9M to 10'1SM), NE (10'6M to 10'IOM), OT (10'IlM) and NE (10'8M)
combined, the NO synthesis inhibitor, N-nitro-L-arginine methyl ester (LNAME, 10'6M),
the kainite receptor antagonist, NBQX (10'6M), the alpha-1 adrenergic receptor
antagonist, prazosin (PRZ, 10'6M), the alpha-2 receptor adrenergic antagonist, yohimbine
(YO, 10'6M), the OT receptor antagonist, [d(CH2)s, Tyr (Me)2, ORN8] vasotocin, (OTA,
10'6M), or combinations thereof. Following each 30 minute test incubation, the medium
was removed and stored at -80°C until assayed for GnRH and/or nitrate/nitrite content.

Lowry Protein Assay

The amount of protein for each tissue sample was determined using a modified
Lowry protein assay. Following overnight incubation in 0.5 ml IN NAOH, tissue
samples were vortexed until the solutions were homogenous. Tubes were labeled Blank,
A-D in duplicate (to construct a standard protein curve), and 1-N in duplicate for the
number o f samples. For determination o f a standard protein curve, standard stock
solutions were prepared from a stock solution of one gram bovine serum albumin
(fraction V) (BSA)/ml H2O. The standard curve was constructed by adding 50 ul of
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distilled H2O (blanks) and 50 ul o f distilled H2O containing 0 ug —50 ug protean to the
appropriate tubes, followed by 50 ul IN NAOH. The proper dilution aliquot o f sample
was then added to the appropriately labeled tubes, followed by distilled H 2O to b rin g total
volume up to 100 uL. Reagent ‘A’ was then prepared by adding Sodium Carbonate:
Cupric Sulfate: KNa Tartrate in that order in the following proportion — 100: 1 : 1 . One
milliliter o f reagent A was then added to each assay tube, with each tube vortexed
following addition. Ten minutes following the addition of reagent ‘A’ to each tu b e, 100
ul folin reagent (phenol: distilled H 2O at 1:1) was added, and each tube was wortexed
following each addition. Thirty minutes following the first addition o f folin reagent,
standards and samples were read at a 660 nm wavelength using a Stafford III
spectrophotometer (Gilford Instruments, Oberlin, OH). A standard curve was manually
constructed by taking the average number of fluorescent units o f each pair o f standard,
subtracting out the average blank, then dividing the result with the known anmount of
protein (in micrograms) for each pair. The average of these numbers was divided into the
counts for each dilution of unknown sample (minus blank), and the total m icrogram s of
protein determined from the dilution factor.

Radioimmunoassay

Radioimmunoassays (RIA) were performed using standard double-antibody
GnRH RIA kits (Peninsula Laboratories, Inc., San Carlos, CA). The assay is based, on the
competition between l25I-GnRH and unlabeled peptide (either standard or unknown)
binding to a specific primary antibody added at a dilution of 1:20,000. An increase in the
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concentration o f standard or unknown GnRH peptide reduces the amount o f 125I-GnRH
able to bind to the antibody. By measuring the amount of labeled GnRH bound as a
percentage of total binding possible for each standard reaction mixture, a standard curve
was constructed. The amount o f GnRH in unknown samples was then determined using
the standard curve.
Following reconstitution o f RIA buffer, standard GnRH peptide, and rabbit-anti
GnRH, a standard dilution series was created (Table 2-1).

Table 2-1: GnRH Peptide Dilution Series
Tube

Sample

RIA Buffer GnRH

Stock

powder

1ml

O

GnRH/100ul

12.8ug/ml

-

40ul stock 960ul

5.12ng/ml

512pg/100ul

A

10ul O

990ul

2.56ng/ml

256pg/100ul

B

500ul A

500ul

1.28ng/ml

128pg/100ul

C

500ul B

500ul

0.64ng/ml

64pg/100ul

D

500ul C

500ul

0.32ng/ml

32pg/100ul

E

500ulD

500ul

0.16ng/ml

16pg/100ul

F

500ul E

500ul

0.8ng/ml

8pg/100ul

G

500ul F

500ul

0.4ng/ml

4pg/100ul

H

500ul G

500ul

0.2ng/ml

2pg/100ul

1

500ul I

500ul

0.1ng/ml

1pg/100ul

Tubes were then labeled in triplicate TA (total activity), NSB (non-specific
binding), and in quintuplicate TB (total binding), and appropriately for the standard
curve. Two hundred microliters o f RIA buffer was added to the TA and NSB tubes, and
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100 ul to TB tubes. One hundred microliters o f standard H through A was pipetted in
triplicate into tubes #12-44, starting with the lowest concentration (tube H) and
continuing with higher concentrations through tube A. Ten microliters, 5 ul, or lul of
unknown sample was then added to tubes #45 and up, and the total amount in each tube
was brought up to 100 ul by adding RIA buffer. Primary antibody was then added to all
but the TA and NSB tubes, and each tube was vortexed. All tubes were then covered with
aluminum foil and allowed to incubate overnight (16-24hrs) at 4°C.
On the second day of the assay, l25I-GnRH was reconstituted with 1 ml of RIA
buffer, and mixed thoroughly. The tracer was diluted to a concentration of approximately
25,00 cpm/100 uL. One hundred microliters o f tracer was added to each test tube in the
assay, they were vortexed, covered and allowed to incubate overnight (16-24hrs) at 4°C.
On the third day of the assay, a secondary Goat Anti-Rabbit IgG serum was
reconstituted to a concentration of 1:22, and 100 ul was added to every test tube. Normal
Rabbit Serum was then reconstituted to a concentration o f 3% and 100 ul added to each
tube. All tubes were vortexed and allowed to incubate at room temperature for 90
minutes. Five hundred microliters o f RIA buffer was then added to each tube, and all but
the TA tubes were vortexed, then centrifuged in a Beckman Model J-6B centrifuge for 35
minutes at 2,500 RPM. Supernatant from the centrifuged tubes was carefully aspirated,
leaving a pellet. Pellets containing bound ligand-antibody from all tubes were then
counted using a gamma counter (Apex Automatic Gamma Counter, ICN Micromedia
Systems, Model 28026). Software by Isodata was used in order to quantitate a standard
curve, and calculate the number of picograms GnRH per tube for unknown samples.
Final data were reported as nanograms GnRH/mg protein/ml/hour.
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Measurement of Nitric Oxide; The Griess Reaction
NO was measured using nitrate/nitrite assay kits (Cayman Chemical, Cat #
780001). NO is produced in trace amounts in neurons and other cells, and is rapidly
scavenged to nitrates and nitrites (Tl/2 = 4 seconds). For this to occur, NO undergoes a
series o f reactions with several molecules present in biological fluids, including:

NO + 0 2- -> 0 N 0 2. + F r ^ NO j. + ET

2NO + 0 2 -> N20 4 + H20 -> N 0 2. + N 0 3

NO + N 0 2 -> N20 3 + H20 -> 2 N 02.

The final in vivo products of NO are nitrite (N 02.) and nitrate (N 0 3.). The relative
proportion of nitrite/nitrate is variable and cannotbe predicted withcertainty. Thus, the
best index for total NO production is the sum of both, and that iswhat was measured in
these assays. Once conversion o f nitrate to nitrite was completed, Griess Reagents are
added. These convert nitrite into a deep purple azo compound. Photometric measurement
of the absorbance due to this azo chromophore accurately determines nitrite
concentration when compared to standard curves.
The assay was run as follows: the assay buffer was diluted to 100 ml with HPLCgrade water. This buffer was used to reconstitute nitrate reductase, enzyme cofactors, and
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nitrate standard. One-tenth o f the reconstituted nitrate standard was then added to 0.9 ml
assay buffer and vortexed. Using this diluted standard, a standard curve was made in a 96
well plate as depicted in Table 2-2 (with the addition o f two blank wells filled with 200 ul
o f buffer only):

Table 2-2. Preparation o f Standard Nitrate/Nitrite Curve
Well

Nitrate Standard Assay

Nitral

Buffer
A1

Oul

80ul

OuM

B1

3ul

77ul

3uM

C1

6ul

74ul

6uM

D1

9ul

71 ul

9uM

E1

12ul

68ul

12uM

F1

15ul

65ul

15uM

G1

18ul

62ul

18uM

H1

21 ul

59ul

21 uM

11

24ul

56ul

24uM

Eighty microliters of unknown sample was then added to the necessary number o f wells.
Ten microliters of enzyme cofactor mixture was then added to each well, followed by 10
microliters of nitrate reductase (except blank wells). The plate was then covered with a
plate cover, and incubated at room temperature for 2 hours. After this incubation time, 50
ul o f Griess reagent 1 was added to the standards and unknowns, followed by 50 ul of
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Griess reagent 2. Photometric measurement of absorbance was then made at 540 nM
using a microplate reader (Molecular Devices, Thermomax Microplate Reader) running
Softmax Pro vl.2 software. A standard curve was generated using the software, and the
micromolar content of nitrite in each sample well was determined.

Statistics
Statistics for these experiments were performed using either Microsoft Excel (raw
data entry, mean), or Prism Graph Pad software. Comparisons between pairs of
individual groups were made using the student’s t-test, and comparisons between 3 or
more groups by one-way analysis of variance plus the Newman-Keuls post-test. The level
o f probability used as the minimum criterion of significance was p < 0.05 for all
experiments. Because basal levels of nitrate/nitrite release varied between animals, but
relative patterns of reactivity to the treatments did not, in the case o f the nitrate/nitrite
assays, each animal was it’s own control. Basal secretion was considered as 100%, and
nitrate/nitrite levels were graphically expressed as percent of basal control. Levels of
significance for the NO studies were determined using raw data.
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Figure 2-1. Vaginal cytology on metestrus, the first day of the estrous cycle

Vaginal cytology on metestrus reveals a sea of leukocytes, which devour the
comified cells of estrus as the animal begins another estrous cycle.
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Figure 2-2. Vaginal cytology on diestrus, the second day o f the estrous
cycle

Vaginal cytology on diestrus reveals a small number o f cells, o f mixed type.
Cells from the previous estrous cycle are nearly gone, and a new uterine
lining is forming.
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Figure 2-3. Vaginal cytology on proestrus, the third day o f the estrous cycle

Vaginal cytology on proestrus, when the GnRH surge occurs, reveals small,
round, nucleated epithelial cells which are often clumped together in strands.
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Figure 2-4. Vaginal cytology on the final day of the cycle, estrus

Vaginal cytology on estrus reveals large, comified cells lacking nuclei.
These provide nutrition for any ovum that might have been fertilized and
implanted.
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Chapter 3: Results
Oxytocin Stimulates GnRH Release From the Proestrous BH But Not ME
Whether or not OT stimulates GnRH release from hypothalamic explants in order
to cause its stimulation o f proestrous LH in vivo is unknown. To address this question,
the ability o f OT to stimulate GnRH release from proestrous ME explants, where GnRH
nerve terminals are located and GnRH is released into portal capillaries was tested. Also
tested was the ability of OT to stimulate GnRH release from proestrous BH explants,
which included the ME as well as areas of the rostral hypothalamus containing GnRH
cell bodies.
As illustrated in Figure 3-1, OT (10 ' l3M and 10 ~IlM) stimulated GnRH release
from BH explants harvested on the afternoon of proestrus from normally cycling female
rats. However, OT in the same concentrations failed to stimulate GnRH release from ME
explants on proestrus. Since OT did not stimulate GnRH release from isolated ME
fragments, a dose-response curve for OT- (10 ' I5M to 10 '9M) induced stimulation of
GnRH from intact proestrous BH explants was constructed (Figure 3-2). The doseresponse curve showed that OT- induced GnRH release from the BH occured at
concentrations as low as 10'13 M, and and increased in a dose-dependent manner from 10
-11M to 10 "9M.
In summary, the data demonstrate that the connectivity found in the intact BH is
necessary for OT to stimulate GnRH release in a dose-dependant manner.
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Figure 3-1. OT- induced stimulation of GnRH from the ME versus the BH
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In vitro release of GnRH from either median eminence (ME) or basal
hypothalamus (BH) explants obtained a t 1500hrs from normally cycling,
proestrous female Sprague-Dawley rats. GnRH release is in response to
buffer alone (control), or buffer containing oxytocin (OT, 10'UM or 10~I3M).
Column heights represent mean GnRH (ng/mg protein/ml/hr) released, and
vertical lines above columns denote tihe S.E.M. N=8 animals for all
treatments. *, significantly different from basal control values (P<0.01).
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Figure 3-2. Dose-response curve for OT- induced stimulation of GnRH
release from proestrous BH

Control
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OT (M olar C o n c e n tra tio n )

In vitro release of GnRH from basal hypothalamus (BH) explants obtained
at 1500hrs from normally cycling proestrous female Sprague-Dawley rats.
GnRH secretion is in response to buffer alone (control), or buffer with
oxytocin (OT, 10‘9M to 10‘I5M). Column heights represent mean GnRH
(ng/mg protein/ml/hr) released, and vertical lines above columns denote the
S.E.M. N=8 animals for all treatments. *, significantly different from basal
control values (P<0.01).
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OT- Stimulation of Proestrous GnRH release: Mechanism of action
In order to examine the mechanisms by which OT induces stimulation o f GnRH
release from proestrous BH, the ability o f antagonists of neurotransmitters/receptors
thought to be involved in the generation o f the preovulatory GnRH surge were tested.
The antagonists used included: 1) the OT receptor antagonist, [d(CH 2)s, Tyr (Me)2,
ORN8] vasotocin

(OTA); 2) the NO synthesis inhibitor, LNAME; 3) the alpha-L

adrenergic receptor antagonist, prazosin; 4) the alpha-2 adrenergic receptor antagonist,
yohimbine; and 5) the glutamatergic kainate receptor antagonist, NBQX.
As depicted in Figures 3-3 thru 3-7, OT’s ability to stimulate GnRH release from
proestrous BH explants was blocked by both OT receptor antagonism (P<0.01) and by
inhibition of NO synthesis (P<0.01). These results indicate that OT stimulates GnRH
secretion from proestrous BH explants via an OT receptor mediated mechanism which
works, at least in part, by the stimulation o f NO. Receptor antagonists for alpha- 1 and
alpha-2 adrenergic receptors did not attenuate OT’s ability to stimulate GnRH release in
vitro from proestrous BH explants, nor did the glutamatergic kainate receptor antagonist
NBQX. These results indicate that alpha-1 and alpha-2 adrenergic receptors do not
mediate OT’s stimulation o f GnRH from proestrous BH explants. This would appear to
rule out direct OT- induced stimulation o f NE as a cause of OT’s effects on GnRH
release. Finally, glutamatergic kainate receptor antagonism failed to attenuate OT’s
stimulation of GnRH release from BH tissues on proestrus. The data support the theory
that OT does not require activation of alpha- adrenergic, nor kainate receptors to
stimulate GnRH release. It does not, however, diminish the possibility that these systems
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may influence OT neurons, or work together or independently in order to cause the
normal preovulatory surge of GnRH and LH.
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Figure 3-3. Effect o f kainate receptor antagonism on OT- induced GnRH
release from proestrous BH
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In vitro release of GnRH from basal hypothalamus (BH) explants obtained at
1500hrs from normally cycling proestrous female Sprague-Dawley rats.
GnRH release is in response to buffer alone (control), or buffer containing
oxytocin (OT, 10~llM) and/or the kainate receptor antagonist NBQX (10*
6M). Column heights represent mean GnRH (ng/mg protein/ml/hr) released,
and vertical lines above columns denote the S.E.M. N=8 animals for all
treatments. *, significantly different from basal control values (P<0.01).
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Figure 3-4. Effect o f alpha-1 adrenergic antagonism on OT- induced GnRH
release from proestrous BH
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In vitro release o f GnRH from basal hypothalamus (BH) explants obtained at
1500hrs from normally cycling proestrous female Sprague-Dawley rats.
GnRH release is in response to buffer alone (control), or buffer containing
oxytocin (OT, 10'11M), and/or the alpha-1 adrenergic receptor antagonist
prazosin, (PRZ, 10"6M). Column heights represent mean GnRH (ng/mg
protein/ml/hr) released, and vertical lines above columns denote the S.E.M.
N=8 animals for all treatments. *, significantly different from basal control
values (PO.OOl).
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Figure 3-5. Effect of alpha-2 adrenergic antagonism on OT- induced GnRH
from proestrous BH
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T re a tm e n t
In vitro release o f GnRH from basal hypothalamus (BH) explants obtained at
1500hrs from normally cycling proestrous female Sprague-Dawley rats.
GnRH release is in response to buffer alone (control), or buffer containing
oxytocin (OT, 10'lIM), an/or the alpha-2 adrenergic receptor antagonist
yohimbine (YO, 10'6M). Column heights represent mean GnRH (ng/mg
protein/ml/hr) released, and vertical lines above columns denote the S.E.M.
N=8-9 animals for all treatments. *, significantly different from basal control
values (P<0.001).
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Figure 3-6. Effect o f NOS inhibition on OT- induced GnRH release from
proestrous BH
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In vitro release of GnRH from basal hypothalamus (BH) explants obtained at
1500hrs from normally cycling proestrous female Sprague-Dawley rats.
GnRH release is in response to buffer alone (control), or buffer containing
oxytocin (OT, 10'lIM), and/or the nitric oxide synthesis inhibitor LNAME,
(10'lIM). Column heights represent mean GnRH (ng/mg protein/ml/hr)
released, and vertical lines above columns denote the S.E.M. N=8 animals
for all treatments, *, significantly different from basal control values
(PO.OOl).
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Figure 3-7. Effect o f OT receptor antagonism on OT- induced GnRH
release from proestrous BH
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In vitro release of GnRH from basal hypothalamus (BH) explants obtained at
1500hrs from normally cycling proestrous female Sprague-Dawley rats.
GnRH release is in response to buffer alone (control), or buffer containing
oxytocin (OT, 10*llM), and/or an oxytocin receptor antagonist (OTA, 10'
6M). Column heights represent mean GnRH (ng/mg protein/ml/hr) released,
and vertical lines above columns denote the S.E.M. N=8 animals for all
treatments. *, significantly different from basal control values (P<0.01).
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Norepinephrine Stimulates GnRH Release On The Afternoon O f Proestrus
NE has previously been implicated in the control o f proestrous GnRH release. In
order to further examine its role in stimulating GnRH release, the following studies were
performed to 1) determine whether NE stimulates GnRH release from proestrous BH
explants in vitro, 2) examine the dose-response relationship for NE stimulation of GnRH
from proestrous BH explants, 3) determine whether NE stimulates GnRH from BH
explants via alpha-1 or alpha-2 adrenergic receptors, and 4) determine the effect of OT
receptor antagonism on NE- induced stimulation o f GnRH from proestrous BH explants.
As depicted in Figure 3-8, NE stimulated GnRH release from proestrous BH
explants in vitro. The effect o f NE on GnRH did not dramatically increase as the dose
rose from 10'8M to 10‘6M, indicating the system was near saturation. The ability of NE to
stimulate GnRH release was blocked by the alpha-1 adrenergic receptor antagonist,
prazosin (Figure 3-9, PO.OOl), but not the alpha-2 adrenergic receptor antagonist,
yohimbine, (Figure 3-10). Administration of an OT- receptor antagonist attenuated the
NE- induced release of GnRH from proestrous BH explants such that NE- induced
stimulation o f GnRH release was no longer significant in the presence of an OTA (Figure
3-11).
These results confirm that NE stimulates the release o f GnRH from proestrous
BH. That this effect was blocked by alpha-1, but not alpha-2 adrenergic receptor
antagonism indicates NE is working through alpha-1 adrenergic receptors to stimulate
GnRH secretion from proestrous BH explants. That OT- receptor antagonism also the
inhibited NE- induced GnRH stimulation indicates that NE may, in part, be working
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through activation o f the OT neurotransmitter system to stimulate GnRH release from
proestrous BH explants.
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Figure 3-8. Dose- response curve for NE- stimulation o f GnRH release from
proestrous BH
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In vitro release of GnRH from basal hypothalamus (BH) explants obtained at
1500hrs from normally cycling proestrous female Sprague-Dawley rats.
GnRH secretion is in response to buffer alone (control), or buffer with
norepinephrine (NE, 10'6M to 10‘loM). Column heights represent mean
GnRH (ng/mg protein/ml/hr) released, and vertical lines above columns
denote the S.E.M. N=8-10 animals for each treatment. *, significantly
different from basal control values (PO.Ol).
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Figure 3-9. Effect o f alpha-1 adrenergic antagonism on NE- induced GnRH
release from proestrous BH
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In vitro release of GnRH from basal hypothalamus (BH) explants obtained at
1500hrs from normally cycling proestrous female Sprague-Dawley rats.
GnRH release is in response to buffer alone (control), or buffer containing
norepinephrine (NE, 10‘8M), and/or the alpha-1 adrenergic receptor
antagonist prazosin, (PRZ, 10'6M). Column heights represent mean GnRH
(ng/mg protein/ml/hr) released, and vertical lines above columns denote the
S.E.M. N=8 animals for all treatments. *, significantly different from basal
control values (P<0.001).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

49

Figure 3-10. Effect o f alpha-2 adrenergic antagonism on NE- induced
GnRH release from proestrous BH
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In vitro release of GnRH from basal hypothalamus (BE!) explants obtained at
1500hrs from normally cycling proestrous female Sprague-Dawley rats.
GnRH release is in response to buffer alone (control), or buffer containing
norepinephrine (NE, 10'8M), and/or the alpha-2 adrenergic receptor
antagonist yohimbine (YO, 10'6M). Column heights represent mean GnRH
(ng/mg protein/ml/hr) released, and vertical lines above columns denote the
S.E.M. N=9 animals for all treatments, *, significantly different from basal
control values (P<0.01).
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Figure 3-11. Effect o f OT- receptor antagonism on NE- induced GnRH
release from proestrous BH
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In vitro release of GnRH from basal hypothalamus (BH) explants obtained at
1500hrs from normally cycling proestrous female Sprague-Dawley rats.
GnRH release is in response to buffer alone (control), or buffer containing
norepinephrine (NE, 10'8M), and/or an OT receptor antagonist (OTA 10'8M).
Column heights represent mean GnRH (ng/mg protein/ml/hr) released, and
vertical lines above columns denote the S.E.M. N=5 animals for all
treatments, *, significantly different from basal control values (P<0.05).
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Interactions Between NE and OT in Stimulating GnRH Release In Vitro

Recent literature suggests that there is an interaction between NE and OT on the
stimulation o f GnRH release from male BH explants (Rettori et al. 1997). In order to test
whether such an interaction occurs in a female model, the ability o f combined OT/NE to
stimulate GnRH release from proestrous BH explants was tested. Also examined was the
ability of several pharmacological agents to block the combined NE/OT stimulation of
GnRH from proestrous BH explants. These agents were the alpha-1 adrenergic
antagonist, prazosin; the alpha-2 adrenergic antagonist, yohimbine; the NO synthesis
inhibitor, LNAME; and the OT receptor antagonist [d(CH2)s, Tyr (Me)2, ORN8]
vasotocin (OTA).
As depicted in Figure 3-12, both NE and OT, on their own, were able to
significantly stimulate GnRH release from proestrous BH explants above basal control
levels (P<0.01 for NE, P<0.001 for OT). When used in combination, NE/OT stimulated
GnRH to a greater extent than either alone, and the increase in GnRH released when the
two neurotransmitters were used together was synergistic rather than additive. Overall,
combined NE/OT stimulated GnRH to 12.94 + 3.2 ng/mg protein/ml/hour above basal
control levels, whereas the sum o f the stimulation o f GnRH above basal control levels by
each neurotransmitter alone was 6.36 + 1.39 ng/mg protein/ml/hour. NOS inhibition
blocked this synergistic effect (Figure 3-13, PO.OOOl), as did OT receptor antagonism
(Figure 3-14, P<0.01). These results indicate that the combination of NE/OT works to
stimulate GnRH from proestrous BH explants by utilizing NO, and that this is driven, at
least in part, by an OT receptor mediated mechanism.
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Administration o f the alpha-1 adrenergic antagonist, prazosin, reduced the level of
stimulation o f GnRH by NE/OT 3.74 ng/mg protein/ml/hour, which is slightly greater
than the stimulation o f GnRH by NE alone above basal control values (3.11 ng/mg
protein/ml/hour). The level of stimulation o f GnRH by NE/OT in the presence of PRZ
was not significantly different than that by OT alone, and GnRH stimulation by NE/OT
above OT alone was reduced 72% by PRZ (Figure 3-15). This result corroborates
previous findings indicating NE stimulation o f GnRH is at least in part due to alpha-1
adrenergic receptor activation.

Alpha-2 adrenergic antagonism by administration of

yohimbine did not affect the ability o f NE/OT to stimulate GnRH release from proestrous
BH explants (Figure 3-16).
These results indicate that NE and OT act in a synergistic manner to stimulate the
release of GnRH by an OT receptor mediated mechanism, which appears to involve NO.
That alpha-1 adrenergic receptor antagonism by prazosin attenuated the NE/OT
stimulation of GnRH to the level o f OT alone and alpha-2 adrenergic antagonism by
yohimbine had no affect on the NE/OT induced GnRH stimulation indicates NE is
working at least in part through an alpha- 1 adrenergic receptor mediated mechanism to
stimulate proestrous GnRH in vitro, and that this mechanism is not directly involved in
the OT-mediated stimulation of GnRH from proestrous BH explants.
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Figure 3-12. Effect of OT and/or NE on GnRH stimulation from proestrous
BH
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In vitro release of GnRH from basal hypothalamus (BH) explants obtained at
1500hrs from normally cycling proestrous female Sprague-Dawley rats.
GnRH release is in response to buffer alone (control), or buffer containing
norepinephrine (NE, 10'8M), and/or oxytocin (OT, 10'UM). Column heights
represent mean GnRH (ng/mg protein/ml/hr) released, and vertical lines
above the columns denote the S.E.M. N=8 animals for all treatments. *,
significantly different from all other treatment values (P<0.001).
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Figure 3-13. Effect o f NOS antagonism on NE/ OT- induced GnRH release
from proestrous BH
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In vitro release o f GnRH from basal hypothalamus (BH) explants obtained at
1500hrs from normally cycling proestrous female Sprague-Dawley rats.
GnRH release is in response to buffer alone (control), or buffer containing
norepinephrine (NE, 10"8M), oxytocin (OT, 10"nM), and/or the nitric oxide
synthesis inhibitor LNAME (10~UM). Column heights represent mean
GnRH (ng/mg protein/ml/hr) released, and vertical lines above columns
denote the S.E.M. N=8 for all treatments, *, significantly different from all
other treatment values (PO.OOl).
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Figure 3-14. Effect o f administration of an OT receptor antagonist on
NE/OT stimulation o f GnRH from proestrous BH
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In vitro release o f GnRH from basal hypothalamus (BH) explants obtained at
1500hrs from normally cycling proestrous female Sprague-Dawley rats.
GnRH release is in response to buffer alone (control), or buffer containing
norepinephrine (NE, 10'8M), oxytocin (OT, 10'11M), and/or an oxytocin
receptor antagonist (OTA, 10'6M). Column heights represent mean GnRH
(ng/mg protein/ml/hr) released, and vertical lines above columns denote the
S.E.M. N=6-8 animals for all treatments, *, significantly different from all
other treatment values (PO.OOl).
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Figure 3-15. Effect o f alpha-1 adrenergic antagonism on the stimulation of
GnRH from proestrous BH by NE and/or OT
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In vitro release of GnRH from basal hypothalamus (BH) explants obtained at
1500hrs from normally cycling proestrous female Sprague-Dawley rats.
GnRH release is in response to buffer alone (control), or buffer containing
norepinephrine (NE, 10'8M), oxytocin (OT, 10'nM), and/or the alpha-1
adrenergic receptor antagonist prazosin, (PRZ, 10~6M). Column heights
represent mean GnRH (ng/mg protein/ml/hr) released, and vertical lines
above columns denote the S.E.M. N=8 animals for all treatments. *,
significantly different from basal control values (PO.Ol).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

57

Figure 3-16. Effect o f alpha-2 adrenergic antagonism on GnRH stimulation
from proestrous BH by NE and/or OT
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In vitro release of GnRH from basal hypothalamus (BH) explants obtained at
1500hrs from normally cycling proestrous female Sprague-Dawley rats.
GnRH release is in response to buffer alone (control), or buffer containing
norepinephrine (NE, 10'8M), oxytocin (OT, 10'11M), and/or the alpha-2
adrenergic receptor antagonist yohimbine (YO, 10'6M). Column heights
represent mean GnRH (ng/mg protein/ml/hr) released, and vertical lines
above columns denote the S.E.M. N=9 animals for all treatments. *,
significantly different from basal control values (P<0.05).
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OT and NE Stimulation of Nitric Oxide: Mechanisms of Action and Similarities to
GnRH Stimulation

NO has been implicated in the control of GnRH secretion in males following its
stimulation by NE. In order to determine whether NO synthesis and secretion was
stimulated from the same proestrous BH explants as were used in the GnRH studies
presented here, nitrate/nitrite levels were measured using a modified Greiss reaction.
GnRH secretion levels were also measured in these experiments. In addition to basal
secretion levels, stimulated levels o f NO and GnRH secretion were determined following
treatment with NE and/or OT. The ability of an OT receptor antagonist to inhibit OT/NEinduced secretion of NO from proestrous BH explants was also tested.
In combination, NE/OT stimulated NO release more than either neurotransmitter
by itself, and stimulated GnRH in a synergistic manner (Figure 3-17). OT receptor
antagonism attenuated both GnRH and NO release in response to combined NE/OT
(Figure 3-18). Figure 3-19 shows a comparison of the effect o f NE, OT, and NE/OT on
both GnRH and NO in the same animals. These results support the hypothesis that
NE/OT utilizes NO and an OT receptor-mediated mechanism in order to stimulate GnRH
release on the afternoon o f proestrus.
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Figure 3-17. Effect o f NE and/or OT on NO synthesis in proestrous BH
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In vitro release o f nitric oxide (NO), as measured by percent change in
nitrite/nitrate levels versus basal (control), from proestrous basal
hypothalamus (BH) explants obtained at 1500hrs from normally cycling
female Sprague-Dawley rats. NO release is in response to buffer alone
(control), or buffer containing norepinephrine (NE, 10'8M), and/or oxytocin
(OT, 10'hM). Column heights represent mean percent change from basal
secretion levels (1.57 ug/ml + 0.41), and vertical lines above columns
indicate the S.E.M. N=6-8 animals for all treatments, **, significantly
different from basal control (P<0.01) using raw data.
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Figure 3-18. Effect o f addition o f an OT- receptor antagonist on stimulation
o f NO synthesis by NE, and/or OT from proestrous BH
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In vitro release of nitric oxide (NO), as measured by percent change in
nitrite/nitrate levels vs basal (control), from proestrous basal hypothalamus
(BH) explants obtained at 1500hrs from normally cycling female SpragueDawley rats. NO release is in response to buffer alone (control), or buffer
containing norepinephrine (NE, 10'8M), oxytocin (OT, 10'nM), and/or an
oxytocin receptor antagonist (OTA, 10‘6M). Column heights represent mean
percent change from basal secretion levels (1.6 ± 0.41 ug/ml), and vertical
lines above columns indicate the S.E.M. N=6-8 animals for all treatments,
**, significant compared to basal (P<0.01) using raw data.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

61

Percent
NitratesMtrites vs
Basal Control

Figure 3-19. Comparison o f NO and GnRH Stimulation in Proestrous BH
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Comparison o f in vitro stimulation o f GnRH and nitrate/nitrite (NO)
synthesis from proestrous basal hypothalamus (BH) harvested at 1500hrs
from normally cycling female Sprague-Dawley rats.
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Effect O f OT. NE, and NE/OT On GnRH and NO Release From Diestrous and
Estrous BH Explants
Whether there is a difference between the ability o f OT and/or NE to stimulate
GnRH and NO release from BH explants harvested on the afternoon estrus and diestrus
versus proestrus was tested. As shown in Figure 3-20, OT and/or NE, stimulated GnRH
release from diestrous and estrous BH in vitro, but in a different manner than seen on
proestrus. On estrus (Figure 3-20A), NE and OT stimulated GnRH at levels near those
seen on proestrous, but the combination of NE/OT stimulated GnRH significantly less
than seen on proestrus. On diestrus, NE stimulated GnRH more than on either proestrus
or estrus. OT stimulated GnRH on diestrus, but less than on proestrus or estrus. The
combination o f NE/OT stimulated GnRH on diestrus to about the same level as NE did,
and to a significantly lesser degree than on proestrus. Thus, though NE and OT are
capable of stimulating GnRH release on diestrus, estrus, or proestrus, the magnitude of
these responses is altered the and synergism seen on proestrus is absent during other
phases of the estrous cycle.
Figure 3-21 depicts OT-, NE-, and OT/NE- induced stimulation o f NO on estrus
or diestrus versus proestrus. NE stimulated NO synthesis significantly more on estrus
than on diestrus or proestrus. OT had no effect on NO stimulation on estrus, and NE/OT
combined stimulated NO to about the same level as NE. On diestrous, neither NE, OT,
nor a combination o f the two significantly stimulated NO synthesis.

Table 3-1

summarizes the data for both GnRH and NO stimulation by NE and/or OT on proestrus,
estrus, and diestrus.
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These results indicate that NE, OT, and their combination differ in their ability to
stimulate GnRH release and NO synthesis on each day o f the estrous cycle. The most
obvious differences are that the combination of NE/OT stimulates much more GnRH
release and NO synthesis on proestrus than diestrus or estrus, that NE stimulates GnRH
release more on diestrus than on any other day o f the cycle, and that OT is capable of
stimulating GnRH release from the BH to some extent on all days o f the cycle. Although
OT’s greatest influence, and its synergism with NE, is seen only on the afternoon of
proestrus, the ability o f OT and/or NE to stimulate NO and GnRH release appears to be
modulated by other factors, which may include plasma estradiol and progesterone levels.
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A. Estrous GnRH Release

B. Diestrous GnRH Release
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Figure 3-20. Comparison of the ability of oxytocin (OT, 10'nM),
norepinephrine (NE, 10~8M), and OT/NE combined to stimulate GnRH from
estrous, diestrous, and proestrous basal hypothalamus (BH) explants
harvested at 1500hrs from normally cycling Sprague-Dawley rats. Column
heights represent mean GnRH, bars above columns represents the SEM.
N=6-8 animals for each treatment group. *, significantly different all other
treatment groups.
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B. Diestrous NO Synthesis
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Figure 3-21. A comparison o f the stimulation o f nitrate/nitrite (NO)
synthesis and release from BH explants by oxytocin (OT, 10‘nM) and/or
norepinephrine (NE, 10'8M), on the afternoons o f estrus, diestrus, or
proestrus.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

66

Table 3-1. GnRH and NO stimulation from BH explants by NE and/or OT on the
afternoons o f proestrus, estrus, or diestrus.

GnRH (ng/m g protein /m l/h o u r)
P ro e s tru s

E s tru s

D ie stru s

Control

1.90 + 0.47

1.76 + 0.36

1.552 + 0.62

NE

4.24 + 0.68

2.98 + 1.0

10.04 + 5.02

OT

5.92 + 0.71

5.58 + 0.39

5.29 + 1.45

NE/OT

14.84 + 3.20

7.42 + 2.14

8 .5 2 + 1 .5 0

N itrites/N itrates (ug/ml)
P ro e s tru s

E s tru s

D ie stru s

Control

1.57 + 0.41

1.7 + 0.52

1.72 + 0.40

NE

1.8 + 0.26

2.40 + 0.44

2.23 + 0.7

OT

2.38 + 0.38

1.72 + 0.36

2.10 + 1.17

NE/OT

3.65 + 0.98

2.2

1.88 + 0.75

+

0.21
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Chapter 4: Discussion
Although many important factors involved in the generation o f the proestrous
GnRH surge and ovulation have been elucidated, the exact neural mechanisms
controlling this phenomenon remain undetermined. For instance, it has been known for
some time that in mammals, the ovaries communicate the readiness o f the peripheral
reproductive system for ovulation to the brain through the secretion o f estradiol and
progesterone. The CNS then responds to this hormonal information by releasing a large
pulse of GnRH on the afternoon o f proestrus. This in turn causes LH to be secreted from
the pituitary into the peripheral circulation, ultimately resulting in ovulation at the
ovaries. However, it has proven difficult to localize estradiol and progesterone receptors
on GnRH neurons, indicating that there is involvement of other neural systems in
“sensing” the hormonal messages from the ovaries.

Indeed, many neurotransmitter

systems have been implicated in the CNS control of female fertility cycles (see Table 11). However, no single neurotransmitter system, or combination o f transmitter systems,
has been shown to entirely account for the initiation and propagation of the large
preovulatory, proestrous GnRH surge. Thus, despite decades of effort by researchers and
clinicians, the CNS mechanisms involved in female reproductive cycles remain
unelucidated.
As outlined in the introduction section, the research for this dissertation focused
primarily on three neurotransmitter systems that have been previously implicated in
stimulating the preovulatory GnRH surge: NE, OT, and NO. The results o f these studies
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are discussed below, and a model of the mechanisms of interaction between the three
systems is proposed, along with ideas for future work in this field.

Stimulation Of Proestrous GnRH and NO Release

Previous research indicated a role for central OT in the preovulatory, proestrous
LH surge (Johnston et al. 1992). However, whether this effect was due to stimulation of
the hypothalamic hormone responsible for stimulating LH release, GnRH, or because of
some other, non-physiological effect central OT might have on other neuroendocrine
regulators of LH secretion was unknown. The present results demonstrate that OT
stimulated GnRH release from proestrous BH explants, but not ME fragments, where
GnRH nerve terminals reside. This stimulation occurred at concentrations as low as 10"
13M,

and appeared to peak by 10"9M. Thus, the data suggest that the neuroanatomical and

neurochemical connectivity present within the intact BH, which includes the ME (where
GnRH nerve terminals reside), are both necessary and sufficient for very low doses of OT
to stimulate GnRH release on the afternoon of proestrus.
These initial findings lead to a variety of mechanistic hypotheses concerning OT’s
stimulatory influence on proestrous GnRH release. One possibility is that OT may
directly stimulate GnRH release from proestrous BH by stimulating OT receptors located
somewhere on the GnRH neuron, itself. However, OT- receptors have not been clearly
demonstrated on GnRH neurons, leaving the likelihood that the stimulatory effect of OT
on proestrous GnRH release is mediated through some other neural mechanism. As the
BH contains a very large number o f neurotransmitter phenotypes, there are a variety of
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possible intermediaries through which OT may work to stimulate proestrous GnRH
release. The most obvious candidates include other central neurotransmitters implicated
in the stimulation o f proestrous GnRH release, especially NE, which has been shown to
be involved in both the tonic and pulsatile regulation of GnRH secretion (Legan and
Callahan 1999; Gallo 1980). Further, NE and OT have been demonstrated to interact in
the stimulation of GnRH release in males (Rettori et al. 1977), so the possibility that they
also do so in females should be considered. Other possible neurotransmitters OT might
work through to stimulate GnRH from proestrous BH explants include glutamate, which
has been shown to stimulate GnRH release from the ME (Mahesh and Brand 1998), and
NO, which also has been shown to be involved in the stimulation o f proestrous GnRH
release (Bonavera, Kalra, and Kalra 1996), as well as OT- mediated GnRH release from
male MBH tissues (Rettori et al. 1997).
The hypotheses outlined above were addressed in the present research. In order to
confirm that the exogenously applied OT was working through OT receptors and not
related receptors such as those for AVP, the ability of a specific OTA to block the OTinduced stimulation o f GnRH from proestrous BH explants was examined.

OTA

administration completely blocked the OT- induced stimulation o f GnRH release from
proestrous BH explants. These results agree with in vivo data demonstrating a selective
ability o f OT antagonists, but not AVP antagonists to block the proestrous LH surge
(Johnston and Negro-Vilar 1988). Thus, OT appears to stimulate proestrous GnRH and
subsequent LH release through an OT- receptor mediated mechanism.
The ability of NOS inhibition to block the OT- induced stimulation o f proestrous
GnRH was also investigated. Administration o f the NOS inhibitor, LNAME, blocked the
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OT- induced stimulation o f proestrous GnRH release from BH explants. This result was
somewhat expected, as OT has been shown to stimulate GnRH release through an NO
mediated mechanism in males (McCann et al. 1996). Further, NO-ergic neurons have
been observed near GnRH neurons in the BH (Herbison et al, 1997), and NO has been
implicated in the release of GnRH at the level o f the SON and the PVN, where OT
neuron cell bodies are found (Grossman et al. 1994), as well as at the level of the ME
(Rettori et al. 1997).
Whether OT stimulates proestrous GnRH release by activation of the
noradrenergic system was examined by testing the ability o f selective pharmacological
antagonists o f alpha- adrenergic receptors to block OT- induced GnRH release from
proestrous BH explants. The results demonstrated that selective antagonists of alpha-1
and alpha-2 adrenergic receptors (PRZ and YO) failed to block the OT- induced
stimulation o f GnRH release from proestrous BH, indicating that if there is any interplay
between NE and OT on GnRH release, it is not due to OT stimulating NE neurons to
release NE and activate alpha- adrenergic receptors. The ability o f OT to stimulate GnRH
release in the presence of a glutamate anatagonist, NBQX (a specific kainate receptor
antagonist), was also tested. Kainate receptor antagonism did not block the OT- induced
GnRH stimulation from proestrous BH explants. This indicates that kainate receptors also
do not mediate OT’s stimulatory effect on proestrous GnRH release.
In summary, the data from these initial OT studies support the hypothesis that OT
stimulates GnRH release from the BH on the afternoon of proestrus. This event required
the connectivity found within the entire BH, which contains both GnRH terminals and
cell bodies, and did not occur at the level of the ME, where only terminals of GnRH
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neurons reside. Further, the OT- induced release o f GnRH was mediated through an OT
receptor mechanism, as well as through a NOS- mediated mechanism. Kainate, alpha -1
and alpha-2 adrenergic receptor antagonism did not affect OT- induced stimulation of
proestrous GnRH release, indicating that OT does not induce GnRH release by
stimulating glutamate or NE release, and subsequent activation of kainatae or alphaadrenergic receptors.
Having determined that OT stimulates GnRH release from BH explants harvested
on the afternoon o f proestrus, studies to determine the ability o f NE to stimulate GnRH
release from proestrous BH explants, and the mechanisms involved in this effect, were
performed. NE (10'6M to 10'10M) stimulated GnRH release from proestrous BH explants
in vitro in a manner similar to that seen by Nowack and Swerdloff (1985), who found that
NE stimulated GnRH release effectively in doses higher than 1CT10M. The data here also
confirm that increasing doses o f NE beyond 10'8M only modestly increase the release of
GnRH from proestrous BH explants, indicating the system is nearly saturated by NE
levels in this range.
Whether NE- induced stimulation of proestrous GnRH release was mediated by
alpha- adrenergic receptors, or by downstream stimulation of OT- receptor mediated
mechanisms was tested. Alpha-1 adrenergic receptor antagonism by PRZ blocked the
ability of NE to stimulate GnRH inform proestrous BH explants. Alpha-2 adrenergic
receptor blockade by YO did not influence the NE- induced increase in proestrous GnRH
release. Finally, OT receptor antagonism attenuated the ability o f NE to stimulate GnRH
release from proestrous BH explants. These results confirm the observation by others that
NE stimulates GnRH release on the afternoon of proestrus, and that this phenomenon is

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

72

mediated through alpha-1, and not alpha-2, adrenergic receptors (Lee et al, 2000).
Whether this is a direct effect o f NE on GnRH neurons was not proven by these studies.
Although NE projections have been shown in close proximity to GnRH neurons (Gallo
1980), alpha-1adrenergic receptors have not yet been conclusively shown on GnRH
neurons. Thus, it would appear that NE, like OT, might be working through some
downstream mechanism to stimulate GnRH release from the BH on proestrus. The data
here suggest this mechanism could utilize the OT neurotransmitter system, as OTreceptor antagonism attenuated the ability of NE to stimulate GnRH release from
proestrous BH explants. This hypothesized NE- induced OT release and subsequent OT
receptor activation could occur at the level of the PVN or SON, where NE projections are
sent and OT cell bodies are found (Daftary et al. 1998; Sawyer and Clifton 1980). The
result that OT receptor antagonism attenuated but did not entirely block NE- induced
GnRH release was not surprising, as NE has been shown to directly stimulate GnRH
release from ME explants in males in vitro (Contijoch, Johnson and Advis 1990), and the
ME is target o f an adrenergic projection originating in the locus ceruleus (Adler et al.
1983).
Because recent literature has indicated that there might be interactions between
the NE- and OT-ergic systems that could play an important role in the generation of the
preovulatory, proestrous GnRH surge, the interplay between these two neurotransmitter
systems in the stimulation o f GnRH from proestrous BH explants was examined. In
combination, NE/OT

stimulated GnRH release from proestrous

BH

explants

synergistically rather than additively. This represents the first demonstration of this
synergistic effect between OT and NE on GnRH release.
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The mechanisms o f this synergism were investigated. Alpha-1 adrenergic receptor
antagonism by PRZ reduced NE/OT- induced proestrous GnRH release to a level similar
to that seen with OT alone. Alpha-2 adrenergic receptor antagonism by YO did not affect
NE/OT- stimulation o f GnRH release from proestrous BH. Administration o f a selective
OTA blocked proestrous GnRH stimulation by NE/OT. Finally, the NE/OT- induced
release o f GnRH from proestrous BH explants also was blocked by inhibition o f NOS via
administration o f the NOS antagonist, LNAME.
Since the synergistic effect of NE/OT on stimulation o f GnRH release from
proestrous BH explants was blocked by both an OT receptor antagonist, and a NOS
inhibitor, the most important conclusion to be drawn from the present data is that NE and
OT work through alpha-1 adrenergic and OT- receptor mediated mechanisms,
respectively, as well as through a NOS mediated mechanism, in order to synergistically
stimulate proestrous GnRH release. Taking into account the effect o f an OTA on NEinduced stimulation of GnRH release from proestrous BH, it seems that part of this
synergism might be due to NE facilitating OT release, and subsequent stimulation of OT
receptors in the BH in order to stimulate GnRH release. Whether this is a direct effect of
NE on OT neurons, or if another mediating factor is involved cannot be concluded from
the present data. However, the data does confirm the hypothesis that at least part of the
synergism by OT and NE in stimulating GnRH release is through an alpha-1 adrenergic
receptor mediated mechanism, and not an alpha-2 adrenergic receptor mediated
mechanism.
That the doses o f NE and OT which synergistically stimulated GnRH release from
proestrous BH explants were near the maximal effective dose for each transmitter alone
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(as determined by the dose-response curves) suggests that another neural intermediary
must be involved in the effect. That NO might be this intermediary responsible for the
synergistic effect is not surprising. Both NE and OT have been implicated in
hypothalamic NO stimulation (Rettori et al. 1997, Canteros et al. 1996), and NO has been
shown to be involved in the preovulatory, proestrous GnRH surge (McCaan et al. 1999).
NO is a diffusible gas neurotransmitter with a potentially wide target area. This fact,
when viewed in combination with the sparse numbers and wide distribution o f GnRH
neurons, gives rise to the intriguing possibility that NO may be the chief signaling agent
for the stimulation o f proestrous GnRH release. Further, NOS activity is stimulated by
both NE and OT, and has been linked to GnRH stimulation on proestrus (McCann et al.
1998). A plausible hypothesis supported by the current data is that following stimulation
o f NOS by NE and OT, the resultant NO diffuses and recruits the widely scattered, and
few in number, GnRH neurons to release GnRH in a coordinated fashion, ultimately
causing in the large preovulatory GnRH surge which results in the LH surge late in
proestrus, causing ovulation. Previous studies which have concentrated on single
neurotransmitter systems, including NE or OT, have been unable to reproduce the
magnitude o f GnRH or LH surges observed on proestrus in the normally cycling female
rat. The present results suggest that this may have been the result of missing the
synergism demonstrated here for OT/ NE- induced stimulation o f GnRH release.
To summarize the data regarding proestrous GnRH release, OT and NE, alone,
stimulate proestrous GnRH from proestrous BH explants. When used in combination, this
stimulation o f GnRH from proestrous BH explants is synergistic. This effect is blocked
by OT receptor antagonism, as well as by inhibition of NOS.

Alpha-1 adrenergic
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receptor antagonism decreased the NE/OT- induced stimulation o f GnRH somewhat,
indicating a removal o f the NE contribution in stimulating GnRH, whereas alpha-2
adrenergic receptor antagonism had no effect. NE and OT synergistically stimulate
GnRH via a NO mediated mechanism, which is activated in a synergistic manner by an
alpha- adrenergic and OT receptor mediated mechanism, respectively.
The ability o f NE and OT to stimulate NO from the same BH tissues used in
GnRH experiments was tested. Both NE and OT also stimulated NO from proestrous BH
explants beyond basal control levels in vitro. In combination, they stimulated NO in a
manner which appeared additive. Stimulation of NO by NE/OT was attenuated by
addition of an OT receptor antagonist. Due to limitation o f the assay used, it was not
possible to accurately test whether NOS inhibition by LNAME blocked the effect of
NE/OT on NO stimulation, nor whether NE alpha- adrenergic antagonism blocked the
effect. Unfortunately, the assay records these compounds as false positives.
The stimulation o f NO synthesis and release in response to OT and/or NE
reported here could occur in a variety of hypothalamic areas, including the ME, where
there is a rich plexus o f NOS-containing neurons (Canteros et al 1996), in other
hypothalamic areas where NOS- positive and GnRH neurons are found, or in OT neurons
and NE projections. The two main areas where this overlap occurs are the PVN and SON
(Hatakeyama et al. 1996). Future studies will be designed to determine where this NOS
activation occurs in response to NE and/or OT, and on what neuronal processes these
effects are mediated.
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Stimulation of GnRH and NO on Estrus and Diestrus

The ability o f OT and/or NE to stimulate GnRH and N O synthesis and release
from BH explants harvested on the afternoon of estrus and diestrus was also examined.
On estrus, OT or NE alone stimulated GnRH release in a m anner similar to that seen on
proestrus. However, OT/NE- induced stimulation o f GnRH release from estrous BH was
additive, and the level o f GnRH released was only about half o f that seen on proestrus.
Estrous NO secretion was stimulated somewhat by NE, but not O T . NE/OT- induced NO
synthesis was equal to that by NE alone, indicating that OT does not stimulate NOScontaining neurons to produce NO on estrus.
These results were not surprising, as estradiol and progesterone levels remain
somewhat elevated throughout the earlier part of estrus, and this hormonal input could
stimulate the NE and OT systems to be partially primed for inducing GnRH release. That
the synergistic effect o f NE/OT on GnRH release from BH explants was not seen on
estrus suggests that in order to stimulate GnRH release, all three neurotransmitter systems
need to be primed for this event, as they are only on the afternoon o f proestrus. That OT
did not stimulate NO from BH explants harvested on estrus, and <iid not contribute to the
stimulation of NO when used in combination with NE, suggests that the key to the
synergism between NE and OT on stimulation of proestrous G nR H release lies in their
ability to jointly stimulate proestrous NO secretion. This hypothesis is supported by the
results from diestrous BH explants as well (below).
On diestrus, NE- induced stimulation of GnRH release that was, on average,
greater than on estrus or proestrus. The reason for this probably lies in the fact that NE is
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involved in the tonic regulation o f GnRH secretion, and thus the noradrenergic receptor
system remains primed to stimulate GnRH release at any time during the estrous cycle if
enough NE is available, as it is when the neurotransmitter is exogenously applied as in
these experiments. OT also stimulated some GnRH release on diestrus, but not as
significantly above basal levels as it did on estrus or proestrus. In combination, NE/OT
stimulated GnRH release from diestrous BH explants to an even lesser extent than NE
alone (although it should be noted that there was a large amount of variability in levels of
NE- induced GnRH release on diestrus), indicating again that a central component
involved in the stimulation o f GnRH release on proestrus is not at work on other days of
the cycle. This component appears to be NO, as NE and/or OT did not significantly
stimulate NO release from diestrous BH explants. This finding provides further proof that
the key to the synergism between NE and OT in stimulating GnRH release from
proestrous BH explants is the stimulation o f NO.

Model of Mechanisms of Action of NE and OT on the Stimulation of GnRH

Since receptors for neither OT nor NE have been conclusively localized directly
on GnRH neurons, the research presented here examined the intermediary mechanisms
by which NE and/or OT stimulate GnRH release from BH explants harvested on the
afternoon of proestrous. The present data indicate that NE- and OT- stimulation of
proestrous GnRH is at least in part due to stimulation o f NO. Further, NE alpha-1
adrenergic receptor activation was shown to be integral for the NE- induced stimulation
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of GnRH. OT receptor activation is also necessary for both NE- and OT- induced
stimulation o f GnRH release from proestrous BH explants.
A possible model o f the mechanism(s) by which NE and OT synergistically
stimulate GnRH release has been developed based upon both the present results and
previous studies, and is presented in Figure 4-1. In this model, both NE and OT influence
proestrous GnRH release by directly stimulating NO- ergic neurons through activation of
alpha- adrenergic and OT receptors, respectively. This, in turn, causes the release NO.
This NO then diffuses throughout the BH and reaches GnRH neuron processes.
Following activation o f guanylyl cyclase and the subsequent formation of cyclic GMP,
GnRH neurons in the BH are stimulated to release their contents in a coordinated,
synchronized fashion from the ME. Other contingencies touched upon in the model
include a noradrenergic stimulation of OT neurotransmission on the afternoon of
proestrous, when endogenous hypothalamic OT levels are at their peak (Sarkar,
Frautschy and Mitsugi 1992). This phenomenon would thereby increase the amount of
OT- stimulated NO. OT levels are then postulated to be further increased by stimulation
of a positive feedback loop, whereby OT stimulates it’s own release even further to cause
an additional positive influence on the system at the proper time of the reproductive
cycle. Evidence for such an OT- positive feedback system exists (Moos et al. 1998;
Chevaleyre et al. 2000), but its relevance to proestrous GnRH release has not been
examined.
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Future Directions

It is said that valuable research creates more questions than it answers. There are
several questions this research has created regarding the roles o f NE, OT, and NO in the
induction o f the preovulatory, proestrous GnRH surge. Among these is whether OT and
NE would have the same effect on GnRH and LH release in vivo as they do in vitro.
Further, the data does not address, beyond eliminating the ME as the site of action of OT
on GnRH release, the anatomical loci of the events described by the biochemical data
presented here. Thus, to further examine the way these central neurotransmitters interact
to affect GnRH release on the afternoon of proestrus, a number o f different avenues of
research could be pursued. These should include a variety of in vivo and in vitro
anatomical and biochemical studies.
In vivo studies of interest would include determining whether the synergistic
effect of OT/NE on GnRH release seen in vitro also caused a synergistic effect on LH
release from live, normally cycling female rats. To perform these studies, animals would
be fitted with ICV cannulae, and OT, NE, or a combination thereof injected into the third
ventricle on the afternoon o f proestrus, prior to the endogenous GnRH and LH surges.
Subsequent LH release would then be measured from blood plasma taken during a time
course following the injection. Further, the ability of centrally administered OTA and
LNAME to attenuated the synergistic effect of OT and NE on LH release could be
determined using a similar protocol. Such a study could help prove whether OT and NE
exert a similar effect on reproductive-specific hormonal release in vivo as they do in
vitro, with the endpoint to be measured being LH release rather than GnRH. Of course,
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as with any study where agents with more than one potential set of targets are injected
into the intact brain, other neural mechanisms that might indirectly, and nonphysiologically effect, LH release might be stimulated by NE and/or OT, and these would
have to be considered when analyzing the results.
In order to determine the neuroanatomical loci involved in the OT and/or NE
effects on proestrous GnRH release, ICC studies could be performed to determine where
in the BH NE and OT might stimulate GnRH neurons on the afternoon of proestrus, and
what other neurotransmitters or relevant gene transcription products are associated with
the phenomenon. Since GnRH synthesis and release in the female rat is linked to
increased transcription of IEGs such as Fos and Jun (Fin, Steiner and Clifton, 1998),
induction o f these IEGs on proestrus by centrally administered NE and/or OT could be
visualized using ICC techniques and used as markers o f cell activity in order to determine
whether the combination o f NE/OT stimulate Fos and/or Jun in a manner similar to how
they stimulate proestrous GnRH and NO synthesis and release. The results o f these
studies would tell both whether OT and NE synergistically stimulate Fos in the same
fashion as GnRH, and, perhaps more importantly in an anatomical sense, where in the
brain this stimulation occurs. If significantly increased levels of Fos induction were
found, the ability of NOS inhibition, alpha-1 adrenergic and/or OT receptor antagonism
on its induction could then be ascertained to discover whether there is an easily visualized
anatomical basis for the biochemical results presented here.
Several other anatomical localization studies could also be performed in order to
further examine the roles o f OT, NE, and NO in the generation o f the preovulatory GnRH
surge. For instance, co-localization studies could be performed in order to ascertain
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whether alpha-1 adrenergic receptors, and/or OT receptors are found on neurons
expressing NOS in hypothalamic areas known to contain GnRH neurons, as well as
examining where in the BH the increases in NO production occur in response to NE
and/or OT. Studies to determine whether neurons that demonstrated a 15-fold increase in
OT- receptor message expression on the afternoon o f proestrus (Bale et al. 1996) also
express GnRH, OT or NE neurons could also be performed. Also of interest would be
whether alpha adrenergic receptors are found on OT-ergic neurons, since the data
presented here suggests that part of NE effect on proestrous GnRH release is mediated
via NE stimulation o f OT, which in turn stimulates the OT receptor. Another important
question to be addressed is which of the subtypes o f estrogen receptors, estrogen alpha or
estrogen beta (Laflamme et al. 1998), mediate the changes seen in NE concentrations, as
well as OT and OT- receptor synthesis, on proestrus in the BH. This could potentially
help delineate how OT and NE neurons sense the hormonal messages sent by the ovaries
that indicate time is right for ovulation.
Another question that could be addressed by future experimentation is whether
NE/OT stimulation o f proestrous GnRH release is accompanied by increases in 2nd
messenger systems associated with NO and/or other agents implicated in the release o f
GnRH. For example, the question of whether cGMP levels are increased by treatment
with NE/OT to proestrous BH tissues could be examined via biochemical assay. Also,
whether inhibitors o f the formation of cGMP can block the OT/NE effect on proestrous
GnRH release could be examined. Finally, as GnRH synthesis and release is linked to
increases in intracellular calcium levels following stimulation of the IP3/DAG system,
the effect o f inhibitors o f this system on the NE and/or OT-induced stimulation o f GnRH
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from proestrous explants and the effect of OT/NE administration on its formation could
be assessed.

Summary and Conclusions
In summary, the data demonstrated that OT (10'9M to 10'13M) stimulated GnRH
release in vitro from BH, and not the ME explants, on the afternoon of proestrus in
normally cycling female rats. This effect was mediated by an OT- receptor mediated
mechanism, and likely used NO synthesis and release to affect GnRH release. The effect
of OT on GnRH did not appear to be mediated by kainate or adrenergic receptormediated mechanisms. NE (10'6M to 10*IOM) also stimulated the release of GnRH from
proestrous BH explants, through an alpha-1 adrenergic receptor mediated mechanism. In
combination, NE and OT stimulated GnRH release from proestrous BH explants in a
synergistic manner. This synergism was mediated by an NO synthesis mechanism and
involved the stimulation o f both OT and alpha-1 adrenergic receptors. Both NE and OT
also stimulated NO synthesis, as measured by nitrate/nitrite production, on the afternoon
of proestrus in normally cycling female rats. Together, NE and OT stimulated proestrous
NO release in an additive manner. This stimulation was mediated, at least in part, through
an OT- receptor mediated mechanism.
In conclusion, the synergistic stimulation of GnRH release from proestrous BH
explants by OT and NE was due to OT and alpha-1 adrenergic receptor stimulation,
respectively, and the consequent production o f NO. Together, these events may explain
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the role that OT plays in the generation o f the proestrous GnRH and LH surges that result
in ovulation on the afternoon o f proestrous in the cycling female rat.
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Figure 4-1. Model o f the events hypothesized to be involved in the generation o f the
proestrous GnRH surge. In the model, increasing estradiol and progesterone (E/P) levels
being secreted from the ovaries are sensed by norepinephrine (NE) and oxytocin (OT)
neurons in the brain. This results in increased secretion of OT and NE. NE secretion
further increases the amount o f OT produced, as well as stimulating gonadotropinreleasing hormone (GnRH) at the median eminence. Both NE and OT stimulate nitric
oxide production, which further stimulates the release of GnRH and coordinates that
secretion to produce the larve preovulatory surge of GnRH. This ultimately results in the
release of the preovulatory surge o f luteinizing hormone (LH) from the pituitary, causing
ovulation.
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